Advertisement

Sarcopaenia, obesity, sarcopaenic obesity and outcomes following hepatic resection for colorectal liver metastases: a systematic review and meta-analysis

      Abstract

      Background

      Obesity is a risk factor for the development of colorectal cancer. Limited evidence exists about outcomes for obese patients undergoing hepatic resection for colorectal liver metastases (CRLM). Sarcopaenia is characterised by a decline in muscle function and muscle mass. It is associated with poorer outcomes for patients on chemotherapy, but there are limited data for sarcopaenic patients undergoing hepatic resection for CRLM.

      Methods

      Pubmed, Embase, Cochrane Central, Web of Science, SCOPUS, and CINAHL databases were searched for articles which were selected in accordance with PRISMA guidelines. Primary outcomes were overall survival (OS) and disease-free survival (DFS). A random effects meta-analysis was conducted.

      Results

      Thirteen studies were included incorporating 2936 patients. No significant difference was found between obese and non-obese patients in OS (HR 0.81, CI 0.47–1.39, p = 0.44) or DFS (HR 1.0, CI 0.99–1.01, p = 0.98). Sarcopaenia was associated with worse OS (HR 1.65, CI 1.10–2.48, p = 0.01), and increased major post operative complications (OR 1.91, CI 1.16–3.14, p = 0.01). Only one study examined outcomes for sarcopaenic obese patients.

      Conclusion

      Limited evidence exists describing the impact of obesity and sarcopenia on outcomes following hepatic resection for CRLM. Obese patients do not have worse oncological outcomes, whereas sarcopaenia is associated with poorer long-term survival.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to HPB
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rawla P.
        • Sunkara T.
        • Barsouk A.
        Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors.
        Przeglad Gastroenterol. 2019; 14: 89-103
        • Manfredi S.
        • Lepage C.
        • Hatem C.
        • Coatmeur O.
        • Faivre J.
        • Bouvier A.M.
        Epidemiology and management of liver metastases from colorectal cancer.
        Ann Surg. 2006; 244: 254-259
        • Engstrand J.
        • Nilsson H.
        • Strömberg C.
        • Jonas E.
        • Freedman J.
        Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
        BMC Cancer. 2018; 18: 78
        • Arroyo-Johnson C.
        • Mincey K.D.
        Obesity epidemiology worldwide.
        Gastroenterol Clin N Am. 2016; 45: 571-579
        • Ma Y.
        • Yang Y.
        • Wang F.
        • Zhang P.
        • Shi C.
        • Zou Y.
        • et al.
        Obesity and risk of colorectal cancer: a systematic review of prospective studies.
        PLoS One. 2013; 8e53916
        • Caan B.J.
        • Meyerhardt J.A.
        • Kroenke C.H.
        • Alexeeff S.
        • Xiao J.
        • Weltzien E.
        • et al.
        Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS study).
        Cancer Epidemiol Biomark Prev. 2017; 26: 1008-1015
        • Petrelli F.
        • Cortellini A.
        • Indini A.
        • Tomasello G.
        • Ghidini M.
        • Nigro O.
        • et al.
        Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis.
        JAMA Netw Open. 2021; 4e213520
        • Cruz-Jentoft A.J.
        • Bahat G.
        • Bauer J.
        • Boirie Y.
        • Bruyère O.
        • Cederholm T.
        • et al.
        Sarcopenia: revised European consensus on definition and diagnosis.
        Age Ageing. 2019; 48: 601
        • Pamoukdjian F.
        • Bouillet T.
        • Lévy V.
        • Soussan M.
        • Zelek L.
        • Paillaud E.
        Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review.
        Clin Nutr. 2018; 37: 1101-1113
        • Lieffers J.R.
        • Bathe O.F.
        • Fassbender K.
        • Winget M.
        • Baracos V.E.
        Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery.
        Br J Cancer. 2012; 107: 931-936
        • Okuno M.
        • Goumard C.
        • Kopetz S.
        • Vega E.A.
        • Joechle K.
        • Mizuno T.
        • et al.
        Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases.
        Surgery. 2019; 165: 329-336
        • Levolger S.
        • van Vugt J.L.
        • de Bruin R.W.
        • JN I.J.
        Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies.
        Br J Surg. 2015; 102: 1448-1458
        • Eriksson S.
        • Nilsson J.H.
        • Strandberg Holka P.
        • Eberhard J.
        • Keussen I.
        • Sturesson C.
        The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases.
        HPB. 2017; 19: 331-337
        • Peng P.D.
        • Van Vledder M.G.
        • Tsai S.
        • De Jong M.C.
        • Makary M.
        • Ng J.
        • et al.
        Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis.
        HPB. 2011; 13: 439-446
        • Horii N.
        • Sawda Y.
        • Kumamoto T.
        • Tsuchiya N.
        • Murakami T.
        • Yabushita Y.
        • et al.
        Impact of intramuscular adipose tissue content on short- and long-term outcomes of hepatectomy for colorectal liver metastasis: a retrospective analysis.
        World J Surg Oncol. 2020; 18: 68
        • Baracos V.E.
        • Arribas L.
        Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.
        Ann Oncol. 2018; 29: ii1-ii9
        • Liberati A.
        • Altman D.G.
        • Tetzlaff J.
        • Mulrow C.
        • Gøtzsche P.C.
        • Ioannidis J.P.
        • et al.
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
        PLoS Med. 2009; 6e1000100
        • Dindo D.
        • Demartines N.
        • Clavien P.A.
        Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.
        Ann Surg. 2004; 240: 205-213
        • Amptoulach S.
        • Gross G.
        • Kalaitzakis E.
        Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases.
        J Surg Res. 2015; 199: 378-385
        • Furukawa K.
        • Haruki K.
        • Taniai T.
        • Hamura R.
        • Shirai Y.
        • Yasuda J.
        • et al.
        Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases.
        Annals Gastroenterol Surg. 2021; 5: 390-398
        • Kobayashi A.
        • Kaido T.
        • Hamaguchi Y.
        • Okumura S.
        • Shirai H.
        • Kamo N.
        • et al.
        Impact of visceral adiposity as well as sarcopenic factors on outcomes in patients undergoing liver resection for colorectal liver metastases.
        World J Surg. 2018; 42: 1180-1191
        • Langella S.
        • Russolillo N.
        • Forchino F.
        • Lo Tesoriere R.
        • D'Eletto M.
        • Ferrero A.
        Impact of obesity on postoperative outcome of hepatic resection for colorectal metastases the paper is based on a previous communication at 8th Meeting of the Italian Chapter of the IHPBA, November 6-7, 2014, Catania, Italia. Surgery (United States).
        158. 2015: 1521-1529
        • Liu Y.W.
        • Lu C.C.
        • Chang C.D.
        • Lee K.C.
        • Chen H.H.
        • Yeh W.S.
        • et al.
        Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
        Sci Rep. 2020; 10: 6459
        • Lodewick T.M.
        • Van Nijnatten T.J.A.
        • Van Dam R.M.
        • Van Mierlo K.
        • Dello S.A.W.G.
        • Neumann U.P.
        • et al.
        Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?.
        HPB. 2015; 17: 438-446
        • Pathak S.
        • Tang J.M.
        • Terlizzo M.
        • Poston G.J.
        • Malik H.Z.
        Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases.
        Eur J Surg Oncol. 2010; 36: 52-57
        • Shiozawa T.
        • Kikuchi Y.
        • Wakabayashi T.
        • Matsuo K.
        • Takahashi Y.
        • Tanaka K.
        Body composition as reflected by intramuscular adipose tissue content may influence short- and long-term outcome following 2-stage liver resection for colorectal liver metastases.
        Langenbeck's Arch Surg. 2020; 405: 757-766
        • van Vledder M.G.
        • Levolger S.
        • Ayez N.
        • Verhoef C.
        • Tran T.C.
        • Ijzermans J.N.
        Body composition and outcome in patients undergoing resection of colorectal liver metastases.
        Br J Surg. 2012; 99: 550-557
        • Martin L.
        • Birdsell L.
        • Macdonald N.
        • Reiman T.
        • Clandinin M.T.
        • Mccargar L.J.
        • et al.
        Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
        J Clin Oncol. 2013; 31: 1539-1547
        • Prado C.M.
        • Lieffers J.R.
        • McCargar L.J.
        • Reiman T.
        • Sawyer M.B.
        • Martin L.
        • et al.
        Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.
        Lancet Oncol. 2008; 9: 629-635
        • Yugawa K.
        • Itoh S.
        • Kurihara T.
        • Yoshiya S.
        • Mano Y.
        • Takeishi K.
        • et al.
        Skeletal muscle mass predicts the prognosis of patients with intrahepatic cholangiocarcinoma.
        Am J Surg. 2019; 218: 952-958
        • Hamaguchi Y.
        • Kaido T.
        • Okumura S.
        • Kobayashi A.
        • Shirai H.
        • Yagi S.
        • et al.
        Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation.
        Transplantation. 2017; 101: 565-574
        • Valentijn T.M.
        • Galal W.
        • Tjeertes E.K.
        • Hoeks S.E.
        • Verhagen H.J.
        • Stolker R.J.
        The obesity paradox in the surgical population.
        Surgeon. 2013; 11: 169-176
        • Haslam D.W.
        • James W.P.
        Obesity.
        Lancet. 2005; 366: 1197-1209
        • Flegal K.M.
        Excess deaths associated with underweight, overweight, and obesity.
        JAMA. 2005; 293: 1861
        • Lennon H.
        • Sperrin M.
        • Badrick E.
        • Renehan A.G.
        The obesity paradox in cancer: a review.
        Curr Oncol Rep. 2016; 18: 56
        • Saklayen M.G.
        The global epidemic of the metabolic syndrome.
        Curr Hypertens Rep. 2018; 20: 12
        • Mills K.T.
        • Bellows C.F.
        • Hoffman A.E.
        • Kelly T.N.
        • Gagliardi G.
        Diabetes mellitus and colorectal cancer prognosis: a meta-analysis.
        Dis Colon Rectum. 2013; 56: 1304-1319
        • Fischer A.
        • Fuchs J.
        • Stravodimos C.
        • Hinz U.
        • Billeter A.
        • Büchler M.W.
        • et al.
        Influence of diabetes on short-term outcome after major hepatectomy: an underestimated risk?.
        BMC Surg. 2020; 20
        • Waalboer R.B.
        • Meyer Y.M.
        • Galjart B.
        • Olthof P.B.
        • van Vugt J.L.A.
        • Grünhagen D.J.
        • et al.
        Sarcopenia and long-term survival outcomes after local therapy for colorectal liver metastasis: a meta-analysis.
        HPB. 2022; 24: 9-16
        • Simonsen C.
        • de Heer P.
        • Bjerre E.D.
        • Suetta C.
        • Hojman P.
        • Pedersen B.K.
        • et al.
        Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: a meta-analysis.
        Ann Surg. 2018; 268: 58-69
        • Koon-Yee Lee G.
        • Chun-Ming Au P.
        • Hoi-Yee Li G.
        • Chan M.
        • Li H.L.
        • Man-Yung Cheung B.
        • et al.
        Sarcopenia and mortality in different clinical conditions: a meta-analysis.
        Osteoporos Sarcopenia. 2021; 7: S19-S27
        • Vergara-Fernandez O.
        • Trejo-Avila M.
        • Salgado-Nesme N.
        Sarcopenia in patients with colorectal cancer: a comprehensive review.
        World J Clin Cases. 2020; 8: 1188-1202
        • Blauwhoff-Buskermolen S.
        • Versteeg K.S.
        • de van der Schueren M.A.E.
        • den Braver N.R.
        • Berkhof J.
        • Langius J.A.E.
        • et al.
        Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer.
        J Clin Oncol. 2016; 34: 1339-+
        • Trejo-Avila M.
        • Bozada-Gutiérrez K.
        • Valenzuela-Salazar C.
        • Herrera-Esquivel J.
        • Moreno-Portillo M.
        Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis.
        Int J Colorectal Dis. 2021; 36: 1077-1096
        • Tanji Y.
        • Furukawa K.
        • Haruki K.
        • Taniai T.
        • Onda S.
        • Tsunematsu M.
        • et al.
        Significant impact of cachexia index on the outcomes after hepatic resection for colorectal liver metastases.
        Ann Gastroenterol Surg. 2022; https://doi.org/10.1002/ags3.12578
        • Rolland Y.
        • Abellan van Kan G.
        • Gillette-Guyonnet S.
        • Vellas B.
        Cachexia versus sarcopenia.
        Curr Opin Clin Nutr Metab Care. 2011; 14: 15-21
        • Ali S.
        • Garcia J.M.
        Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review.
        Gerontology. 2014; 60: 294-305
        • Marcus R.L.
        • Addison O.
        • Kidde J.P.
        • Dibble L.E.
        • Lastayo P.C.
        Skeletal muscle fat infiltration: impact of age, inactivity, and exercise.
        J Nutr Health Aging. 2010; 14: 362-366
        • Yoshimura Y.
        • Wakabayashi H.
        • Yamada M.
        • Kim H.
        • Harada A.
        • Arai H.
        Interventions for treating sarcopenia: a systematic review and meta-analysis of randomized controlled studies.
        J Am Med Dir Assoc. 2017; 18: 553e1-553e16
        • Dunne D.F.J.
        • Jack S.
        • Jones R.P.
        • Jones L.
        • Lythgoe D.T.
        • Malik H.Z.
        • et al.
        Randomized clinical trial of prehabilitation before planned liver resection.
        Br J Surg. 2016; 103: 504-512
        • Carli F.
        • Bousquet-Dion G.
        • Awasthi R.
        • Elsherbini N.
        • Liberman S.
        • Boutros M.
        • et al.
        Effect of multimodal prehabilitation vs postoperative rehabilitation on 30-day postoperative complications for frail patients undergoing resection of colorectal cancer: a randomized clinical trial.
        JAMA Surg. 2020; 155: 233-242
        • Onerup A.
        • Andersson J.
        • Angenete E.
        • Bock D.
        • Börjesson M.
        • Ehrencrona C.
        • et al.
        Effect of short-term homebased pre- and postoperative exercise on recovery after colorectal cancer surgery (PHYSSURG-C): a randomized clinical trial.
        Ann Surg. 2022; 275: 448-455
        • Runkel M.
        • Diallo T.
        • Bamberg F.
        • Fichtner-Feigl S.
        • Lang S.A.
        Are visceral obesity and sarcopenia postoperative risk factors for patients undergoing hepatic resections for synchronous colorectal liver metastases?.
        Oncol Res Treat. 2020; 43: 56
        • Peterson S.J.
        • Mozer M.
        Differentiating sarcopenia and cachexia among patients with cancer.
        Nutr Clin Pract. 2017; 32: 30-39
        • Mourtzakis M.
        • Prado C.M.
        • Lieffers J.R.
        • Reiman T.
        • McCargar L.J.
        • Baracos V.E.
        A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.
        Appl Physiol Nutr Metabol. 2008; 33: 997-1006
        • Cespedes Feliciano E.M.
        • Avrutin E.
        • Caan B.J.
        • Boroian A.
        • Mourtzakis M.
        Screening for low muscularity in colorectal cancer patients: a valid, clinic-friendly approach that predicts mortality.
        J Cachexia Sarcopenia Muscle. 2018; 9: 898-908
        • Berardi G.
        • Antonelli G.
        • Colasanti M.
        • Meniconi R.
        • Guglielmo N.
        • Laurenzi A.
        • et al.
        Association of sarcopenia and body composition with short-term outcomes after liver resection for malignant tumors.
        JAMA Surg. 2020; 155e203336